所有图片(1)

Key Documents

COO原产地证书/COA分析证书

View All Documentation

PHR1446

雷米普利

Name: 雷米普利
Brand: SIAL

Pharmaceutical Secondary Standard; Certified Reference Material

别名:

Tritace, [2S,3aS,6aS]-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid

登录查看公司和协议定价

所有图片(1)

About This Item

经验公式（希尔记法）:

C₂₃H₃₂N₂O₅

CAS号:

87333-19-5

分子量:

416.51

MDL编号:

MFCD00865775

UNSPSC代码:

41116107

PubChem化学物质编号:

329822606

NACRES:

NA.24

推荐产品

Slide 1 of 10

1 of 10

Sigma-Aldrich

R0404

雷米普利

Supelco

PHR1185

苯磺酸氨氯地平

R0145000

雷米普利

Supelco

PHR3128

Ramipril Related Compound A

Supelco

PHR1084

二甲双胍盐酸盐

Supelco

PHR1355

对二甲氨基苯甲酸异辛酯

Supelco

PHR1928

瑞舒伐他汀钙

Supelco

PHR1032

氢氯噻嗪

Supelco

PHR1602

氯沙坦钾

Supelco

PHR1117

2,6-二叔丁基-4-甲基苯酚

等级

certified reference material
pharmaceutical secondary standard

质量水平

300

Agency

traceable to BP 751
traceable to Ph. Eur. R0145000
traceable to USP 1598303

API类

ramipril

CofA

current certificate can be downloaded

包装

pkg of 1 g

技术

HPLC: suitable
gas chromatography (GC): suitable

应用

pharmaceutical (small molecule)

格式

neat

储存温度

2-8°C

SMILES字符串

O=C(N1[C@](CCC2)([H])[C@]2([H])C[C@H]1C(O)=O)[C@H](C)N[C@H](C(OCC)=O)CCC3=CC=CC=C3

InChI

1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m0/s1

InChI key

HDACQVRGBOVJII-JBDAPHQKSA-N

基因信息

human ... ACE(1636)

正在寻找类似产品? 访问产品对比指南

一般描述

Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.

Ramipril is an angiotensin-converting-enzyme (ACE) inhibitor, which acts on the renin angiotensin aldosterone system. It is widely used in reducing hypertension by the suppression of the effects of angiotensin II at its receptor, thereby blocking the renin-angiotensin system.

应用

Ramipril may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using spectrophotometric technique and high-performance liquid chromatography technique.

These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

生化/生理作用

Angiotensin converting enzyme (ACE) inhibitor.

分析说明

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

其他说明

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

附注

To see an example of a Certificate of Analysis for this material enter LRAC3757 in the slot below. This is an example certificate only and may not be the lot that you receive.

1598303

雷米普利, United States Pharmacopeia (USP) Reference Standard

1598314

1598347

1598323

1598338

BP751

雷米普利, British Pharmacopoeia (BP) Reference Standard

BP754

Ramipril impurity K, British Pharmacopoeia (BP) Reference Standard

象形图

GHS08

警示用语：

Danger

危险声明

H360FD

预防措施声明

P201 - P202 - P280 - P308 + P313 - P405 - P501

危险分类

Repr. 1B

储存分类代码

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable

从最新的版本中选择一种：

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Simultaneous determination of ramipril, hydrochlorothizide and telmisartan by spectrophotometry

Bankey S, et al.

International Journal of ChemTech Research, 1(2), 183-188 (2009)

A Spectrophotometric method for the determination of ramipril in solid dosage forms

Afleroho EO, et al.

Tropical Journal of Pharmaceutical Research, 11(2), 275-279 (2012)

A validated HPLC method for analysis of atorvastatin calcium, ramipril and aspirin as the bulk drug and in combined capsule dosage Forms

Patole MS, et al.

International Journal of Pharmaceutical Sciences Review and Research, 4(3), 40-45 (2010)

Development and validation of simultaneous HPLC method for estimation of telmisartan and ramipril in pharmaceutical formulations

Jawla S, et al.

International Journal of PharmTech Research, 2(2), 1625-1633 (2010)

Genotype-based dosage of acenocoumarol in highly-sensitive geriatric patients.

Roberto Lozano et al.

International journal of clinical pharmacology and therapeutics, 53(3), 206-210 (2015-02-12)

Our aim was to determinate the acenocoumarol dose requirement in highly sensitive geriatric patients, based on a minimum of genotype (VKORC1 and CYP2C9) data. We used a Gaussian kernel density estimation test to identify patients highly sensitive to the drug

查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门

Key Documents

雷米普利

Pharmaceutical Secondary Standard; Certified Reference Material

About This Item

推荐产品

属性

等级

质量水平

Agency

API类

CofA

包装

技术

应用

格式

储存温度

SMILES字符串

InChI

InChI key

基因信息

相关类别

说明

一般描述

应用

生化/生理作用

分析说明

其他说明

附注

相关产品

相关产品

安全信息

象形图

警示用语：

危险声明

预防措施声明

危险分类

储存分类代码

WGK

闪点(°F)

闪点(°C)

文件

分析证书(COA)

已有该产品？

同行评审论文

技术服务